3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Mouth Neoplasms
3
Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Squamous Cell
2
Vaccinia
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Gemcitabine
7
durvalumab
6
Oxaliplatin
6
Magnetic Resonance Spectroscopy
6
Leucovorin
6
Cisplatin
6
Specimen Handling
5
Fluorouracil
5
Biopsy
5
Paclitaxel
4
Folfox protocol
4
Taxes
3
Irinotecan
3
pemigatinib
2
pembrolizumab
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Platinum
2
Nivolumab
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Carboplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
zanidatamab
1
ulixertinib
1
tremelimumab
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
cemiplimab
×
30 days
×
Clear all
No trials found.